Cargando…
Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): A health-economic assessment
BACKGROUND: Common variable immunodeficiency disorders (CVID), the most common form of primary antibody deficiency, are rare conditions associated with considerable morbidity and mortality. The clinical benefit of immunoglobulin replacement therapy (IgGRT) is substantial: timely treatment with appro...
Autores principales: | van Wilder, Philippe, Odnoletkova, Irina, Mouline, Mehdi, de Vries, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932530/ https://www.ncbi.nlm.nih.gov/pubmed/33661975 http://dx.doi.org/10.1371/journal.pone.0247941 |
Ejemplares similares
-
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
por: Poto, Remo, et al.
Publicado: (2023) -
Assessing Disease Severity in Common Variable Immunodeficiency Disorders (CVID) and CVID-Like Disorders
por: Ameratunga, Rohan
Publicado: (2018) -
Editorial: Updates on the pathogenesis of common variable immunodeficiency (CVID)
por: Martelius, Timi, et al.
Publicado: (2023) -
The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data
por: Odnoletkova, Irina, et al.
Publicado: (2018) -
Management of liver disease and portal hypertension in common variable immunodeficiency (CVID)
por: Baumert, Lukas S., et al.
Publicado: (2023)